<qa>  What type of treatment has been given to patients who have started treatment with nab-- Patients who have started treatment with nab-paclitaxel monotherapy no further than the third line of chemotherapy for metastatic disease in HER2-negative breast cancer during the period 2012-2014 3 years and who have received at least one cycle of treatment. 